Jan. 8 at 3:19 PM
$VRCA Addition to my last post..👇
This confirmation took place during their formal presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
Key Details from the Confirmation:
The Announcement Date: January 6, 2026.
The Context: CEO Ted White addressed investors, stating that the company had successfully completed the necessary manufacturing and stability testing required by the FDA to address previous concerns.👈😘
The "Class 1" Signal: Verrica also noted their expectation that the FDA will treat this as a Class 1 resubmission, which carries a fast 60-day review cycle.👍
Potential Outcome: If the resubmission occurs this week (as "imminent" suggests), the new PDUFA decision date could land in early-to-mid March 2026.💪👍
